Use of Clindamycin in Pediatric Infections

Marcia L. Buck, Pharm.D., FCCP


Pediatr Pharm. 2008;14(2) 

In This Article


Since its development 40 years ago, clindamycin has become an important alternative in the treatment of serious Gram positive and anaerobic infections. With the increasing incidence of CAMRSA infections in children, it will likely become a more frequent therapy in the pediatric population.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: